Table 2 Correlations between pre-treatment RDW and clinical hematology parameter in patients with breast cancer
Parameters>Median≤Mediant/P-value
Red blood cell, ×10126.0 ±1.66.2 ± 1.9-1.6350.102
White blood cell, ×1098.5 ± 3.58.1 ± 3.41.6650.096
Hemoglobin, g/l131.2 ± 12.5130.4 ± 13.80.8730.383
Platelet, × 109/l241.2 ± 62.3243.8 ± 55.6-0.6320.527
Lymphocyte, 109/l2.1 ± 0.52.0 ± 0.52.8750.004
Fibrinogen, g/l3.1 ± 0.83.0 ± 0.62.0310.043
Total cholesterol, mmol/l1.3 ± 0.81.4 ± 1.1-1.3660.172
Triglyceride, mmol/l1.3 ± 1.11.3 ± 1.00.0000.999
HDL-C, mmol/l1.38 ± 0.321.37 ± 0.310.4560.649
LDL-C, mmol/l3.1 ± 0.673.1 ± 0.80.3890.697
High-sensitivity C-reactive protein, mg/l7.5 ± 4.24.3 ± 5.69.2830.000
Albumin, g/l25.4 ± 10.426.3 ± 12.3-1.1350.257
Fasting plasma glucose, mmol/l6.1 ± 2.15.9 ± 0.91.7790.076